1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Establishment of induced pluripotent stem cells from a patient with 16p13.11 duplication and VPS13B deletion.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          VPS13B deletion and 16p13.11 duplication are related to mental disorders, such as schizophrenia. However, how these variants affect human neurons and contribute to the development of mental disorders is yet to be elucidated. In this study, we generated induced pluripotent stem cells (iPSCs) from a patient with 16p13.11 duplication and VPS13B deletion. The iPSCs indicated pluripotency marker expression and the differentiation capacity into three germ layers in vitro. Therefore, these iPSC lines will be useful tools to further understand the pathophysiology of mental disorders.

          Related collections

          Author and article information

          Journal
          Stem Cell Res
          Stem cell research
          Elsevier BV
          1876-7753
          1873-5061
          Oct 2022
          : 64
          Affiliations
          [1 ] Pathophysiology of Psychiatric Disorders, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Hospital Pharmacy, Nagoya University Hospital, Nagoya, Japan.
          [2 ] Pathophysiology of Psychiatric Disorders, Nagoya University Graduate School of Medicine, Nagoya, Japan; Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan. Electronic address: ariokay@med.nagoya-u.ac.jp.
          [3 ] Pathophysiology of Psychiatric Disorders, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan; Medical Genomics Center, Nagoya University Hospital, Nagoya, Japan.
          [4 ] Pathophysiology of Psychiatric Disorders, Nagoya University Graduate School of Medicine, Nagoya, Japan; Brain and Mind Research Center, Nagoya University, Nagoya, Japan.
          [5 ] Pathophysiology of Psychiatric Disorders, Nagoya University Graduate School of Medicine, Nagoya, Japan; Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan.
          Article
          S1873-5061(22)00233-1
          10.1016/j.scr.2022.102884
          35944312
          dda29f66-6849-4e5c-91fe-c48d8223364e
          History

          Comments

          Comment on this article